TITLE

CORRELATION BETWEEN ATHEROSCLEROTIC PLAQUES MORPHOLOGY AND SEROUS HYPERSENSITIVE C-REACTIVE PROTEIN IN PATIENTS WITH PREMATURE CORONARY HEART DISEASE

PUB. DATE
October 2010
SOURCE
Heart;Oct2010 Supplement, pA112
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "Correlation Between Atherosclerotic Plaques Morphology and Serous Hypersensitive C-Reactive Protein in Patients With Premature Coronary Heart Disease" by Lijian Gao and colleagues is presented.
ACCESSION #
66245758

 

Related Articles

  • THE VALUES OF C - REACTIVE PROTEIN FOR SOME EARLY-DIAGNOSED WITH MYOCARDIAL INFARCTION PATIENTS. VASILE, LAURA-IULIANA; UNGUREANU, EUGEN // Analele Stiintifice ale Universitatii Alexandru Ioan Cuza din Ia;Sep2013, Vol. 14 Issue 3, p43 

    C-reactive protein (CRP) is an indirect risk factor in the acute coronary syndromes [2,13,21]. Its high levels may reflect one of the following cases: an inflammation of the coronary arteries as a response to the infectious agents; the severeness of the inflammatory response within the...

  • Impact of C-reactive protein on treatment of patients with cardiovascular disease. Gortney, Justine Schuller; Sanders, Rhonda Martin // American Journal of Health-System Pharmacy;10/1/2007, Vol. 64 Issue 19, p2009 

    Purpose. The impact of C-reactive protein (CRP) on the treatment of patients with cardiovascular disease is described. Summary. CRP is a marker of coronary heart disease and other disease states. Its release from the liver activates endothelial dysfunction and contributes to atherothrombosis. In...

  • Blood Levels of Inflammatory and Destructive Biomarkers in Coronary Atherosclerosis of Different Severity. Ragino, Yu.; Chernjavski, A.; Polonskaja, Ya.; Tchimbal, S.; Redjkin, D.; Semaeva, E.; Kashtanova, E.; I Voevoda, M. // Bulletin of Experimental Biology & Medicine;May2010, Vol. 149 Issue 5, p587 

    In male patients with coronary atherosclerosis without acute coronary syndrome, the levels of inflammatory-destructive biomarkers of atherosclerotic plaque instability depended on the severity and dissemination of coronary atherosclerosis. The highest levels of C-reactive protein and matrix...

  • Increased YKL-40 levels in patients with isolated coronary artery ectasia: an observational study. Erdoğan, Turaıı; Kocaman, Sinan Altan; Çctiıı, Mustafa; Durakoğlugil, Murtaza Emre; Kırbaş, Aynur; Çanga, Aytun; Yılmaz, Adnan; Doğan, Sıtkı; Çiçek, Yüksel // Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi;Aug2013, Vol. 13 Issue 5, p465 

    Objective: YKL-40, a new biomarker of localized inflammation, is secreted by macrophages within the atherosclerotic plaques. Coronary artery ectasia (CAE) is a clinical entity with unclear etiopathogenesis. Some studies have revealed that CAE may be a form of atherosclerosis that has more...

  • Inflammatory Markers in Coronary Artery Disease: Pathophysiological Mechanisms, Prognostic and Therapeutic Implications. Ikonomidis, Ignatios; Stamatelopoulos, Kimon; Lekakis, John; Th. Kremastinos, Dimitrios // Current Cardiology Reviews;2006, Vol. 2 Issue 3, p173 

    Several inflammatory proteins intervene with endothelium and haemostatic factors leading to plaque formation and rupture. Of these, C-reactive protein (CRP), monocyte/macrophage colony-stimulating factor (MCSF) and interleukin- 6 (IL-6) promote atherogenesis by inducing monocyte-macrophage...

  • A STUDY OF C-REACTIVE PROTEIN AND ITS RELATIONSHIP WITH CHD AND LIPID METABOLISM. Devaki, R. N.; Gowdappa, H. Basavana; Suma, M. N.; Prashanth, V.; Akila, P.; Devi, B. D. Anjali; Deepa, K.; Goud, B. K. Manjunatha; Nayal, Bhavna // International Journal of Pharmaceutical Sciences Review & Resear;Jan/Feb2011, Vol. 6 Issue 2, p125 

    Inflammation is an important feature of atheroma and is associated with activation and proliferation of macrophages, endothelial and smooth muscle cells, the generation of growth factors and cytokines, the presence of other pro-inflammatory mediators, and the activation and deposition of...

  • Prognostic Value of Placental Growth Factor in Patients With Acute Chest Pain. Heeschen, Christopher; Dimmeler, Stefanie; Fichtlscherer, Stephan; Hamm, Christian W.; Berger, Juergen; Simoons, Maarten L.; Zeiher, Andreas M. // JAMA: Journal of the American Medical Association;1/28/2004, Vol. 291 Issue 4, p435 

    Context: Experimental data suggest that placental growth factor (PlGF), a member of the vascular endothelial growth factor family, acts as a primary inflammatory instigator of atherosclerotic plaque instability and thus may be useful as a risk-predicting biomarker in patients with acute coronary...

  • Vulnerable plaque: Pathobiology and clinical implications. Kullo, Iftikhar J.; Edwards, William D. // Annals of Internal Medicine;12/15/98, Vol. 129 Issue 12, p1050 

    Evaluates the pathobiology and clinical implications of vulnerable coronary atherosclerotic plaques. Identification of vulnerable plaques and mechanisms of plaque stabililization; Rupture at the site of a vulnerable atherosclerotic plaque; Improved understanding of the biology of atheromatous...

  • Prothrombotic determinants of coronary atherothrombosis. Ruberg, Frederick L; Loscalzo, Joseph // Vascular Medicine;2002, Vol. 7 Issue 4, p289 

    An acute coronary syndrome (ACS) is the clinical manifestation of a thrombotic event occurring within a coronary artery narrowed by atherosclerosis. This atherothrombotic event is thought to occur following destabilizing changes within the atherosclerotic plaque, rendering it a surface on which...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics